Valuation: AcouSort AB

Market Cap 80.85M 8.31M 7.28M 6.72M 6.27M 11.81M 786M 12.08M 31.21M 388M 31.21M 30.53M 1.35B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 80.85M 8.31M 7.28M 6.72M 6.27M 11.81M 786M 12.08M 31.21M 388M 31.21M 30.53M 1.35B EV / Sales 2026 *
7.63x
EV / Sales 2027 * 5.46x
Free-Float
59.52%
Yield 2026 *
-
Yield 2027 * -
1 day-4.50%
1 week-5.21%
Current month-15.11%
1 month-15.11%
3 months+29.05%
6 months+36.92%
Current year+34.98%
1 week 3.46
Extreme 3.46
4.03
1 month 3.16
Extreme 3.16
5.16
Current year 2.03
Extreme 2.03
5.16
1 year 2.03
Extreme 2.03
5.16
3 years 2.03
Extreme 2.03
28.6
5 years 2.03
Extreme 2.03
32.95
10 years 2.03
Extreme 2.03
32.95
Manager TitleAgeSince
Chief Executive Officer 68 2013-12-31
Director of Finance/CFO 65 2015-12-31
Director TitleAgeSince
Director/Board Member 64 2011-12-31
Chairman 65 2010-12-31
Director/Board Member - 2021-11-30
Change 5-day change 1-year change 3-year change Capi.($)
-4.50%-5.21%+19.00%-75.35% 8.71M
+0.94%+7.83%-4.77%+3.17% 46.2B
+5.79%+16.17%+421.86%+634.63% 38.71B
+1.12%+15.18%+22.74%-12.71% 31.9B
+3.61%+6.69%+20.23%+62.38% 31.12B
+8.02%+6.35%+17.67%+34.73% 23.77B
+1.13%+15.66% - - 16.2B
+1.45%+17.35%+72.11%+127.60% 15.05B
-1.13%+7.40%+12.03%+20.67% 13.74B
-0.60%+6.32%+102.74%+96.28% 13.42B
Average +1.58%+9.93%+75.96%+99.04% 23.01B
Weighted average by Cap. +2.71%+11.43%+95.90%+142.90%

Financials

2026 *2027 *
Net sales 10.6M 1.09M 954K 881K 823K 1.55M 103M 1.58M 4.09M 50.83M 4.09M 4M 176M 14.8M 1.52M 1.33M 1.23M 1.15M 2.16M 144M 2.21M 5.71M 70.97M 5.71M 5.59M 246M
Net income - -
Net Debt - -
Logo AcouSort AB
Acousort AB is a Sweden-based company engaged in the medical technology. The Company develops, produces and sells standalone laboratory products and integrated original equipment manufacturer (OEM) solutions where ultrasound is used to separate, wash and enrich cells, exosomes and other biological particles for research and diagnostics. Its product portfolio includes AcouWash and AcouTrap that are targeting separation, washing and enrichment applications within cell, bacteria and extracellular vesicle research. In addition, the Company develops proprietary bioanalytical and clinical applications based on acoustophoresis, and offers custom-developed acoustophoresis applications.
Employees
11
Date Price Change Volume
26-06-29 SEK 3.820 -4.50% 37,495
26-06-26 SEK 4.000 +6.95% 35,439
26-06-25 SEK 3.740 -6.03% 38,452
26-06-24 SEK 3.980 -0.75% 12,145
26-06-23 SEK 4.010 -0.50% 13,469

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ACOU Stock